Botulinum Toxins Intralesional Injection for Scar Pain
Status:
Unknown status
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
Botulinum toxins has been approved by the FDA to treat chronic migraine. Botox had been shown
to inhibiting the release of inflammatory mediators and peripheral neurotransmitters from
sensory nerve to treat neuropathic pain. In the clinical practice, botox indeed effect in
scar pain. However, investigators need well controlled study to prove this finding and assess
the improvement of scar appearance.
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A Lidocaine Triamcinolone Triamcinolone Acetonide Triamcinolone diacetate Triamcinolone hexacetonide